Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126699751 | 12669975 | 1 | I | 20160817 | 20160821 | 20160821 | PER | US-CELGENEUS-USA-2016085203 | CELGENE | 69.00 | YR | M | Y | 56.30000 | KG | 20160821 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126699751 | 12669975 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | UNKNOWN | 20785 | CAPSULES | ||||||||
| 126699751 | 12669975 | 2 | C | Bortezomib | BORTEZOMIB | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126699751 | 12669975 | 3 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126699751 | 12669975 | 1 | Plasma cell myeloma |
| 126699751 | 12669975 | 2 | Product used for unknown indication |
| 126699751 | 12669975 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126699751 | 12669975 | Unevaluable event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |